Stay updated with breaking news from Repligen Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Comerica Bank boosted its stake in Repligen Co. (NASDAQ:RGEN – Get Rating) by 11.7% in the fourth quarter, HoldingsChannel reports. The firm owned 117,682 shares of the biotechnology company’s stock after buying an additional 12,309 shares during the period. Comerica Bank’s holdings in Repligen were worth $21,850,000 as of its most recent SEC filing. A […]
Inspire Investing LLC lifted its position in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 19.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,163 shares of the biotechnology company’s stock after purchasing an additional 1,320 shares during […]
Benchmark began coverage on shares of Repligen (NASDAQ:RGEN – Get Rating) in a report issued on Monday morning, The Fly reports. The firm issued a buy rating and a $230.00 price objective on the biotechnology company’s stock. RGEN has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft initiated coverage on shares of […]
Repligen Co. (NASDAQ:RGEN – Get Rating)’s stock price shot up 4.5% during mid-day trading on Monday . The company traded as high as $167.87 and last traded at $167.40. 133,416 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 571,400 shares. The stock had previously closed at $160.25. […]
Bank of New York Mellon Corp cut its stake in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 2.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 983,641 shares of the biotechnology company’s stock after selling 23,204 shares during the quarter. Bank of New York Mellon Corp’s holdings in Repligen were worth $184,049,000 […]